SRTD Biotech

SRTD Biotech is an RNA-based biotechnology company that focuses on oncology, infectious, and genetic disorders.

Latest funding

$35.26M Seed · November 9, 2026

Led by Boehringer Ingelheim Venture Fund · Source: finsmes.com

Funding history ↓

Website: srtd-biotech.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biopharma, Oncology.

Stage: Seed.

Based in: Jülich, Germany.

Last round: Nov 9, 2026 · 3 days ago.

On Recent Funding since: Nov 10, 2026.

Signals

Website registeredMay 3, 2022 (4 years old)

Funding rounds

November 9, 2026
Seed · $35.26M
BBoehringer Ingelheim Venture Fund (lead), MMérieux Equity Partners (lead), NNRW.BANK (lead), AAnobis Asset, HHTGF, LLilly Ventures
Source: finsmes.com
May 3, 2022
Website created

Founders and team

BH
Bernd Hoffmann Founder
GL
Georg Lautscham Consultant, CBO & CFO

Investors

Companies like SRTD Biotech

VVariantyx$36M Series B+ · Apr 2024
EElixion BiotechPre Seed · May 2026
VVico Therapeutics$71M Series B+ · Jun 2024
RResalis Therapeutics$10.92M Series A · Jan 2024
SSurf Bio$16M Seed · Apr 2022
AArnatar Therapeutics$50M Series A · Mar 2026

Other companies backed by Boehringer Ingelheim Venture Fund

CCloverleaf Bio$33M Seed · Sep 2026
BBrainomix$25.4M Series B+ · Feb 2026
WWellth$36M Series B+ · Sep 2025
NNuevocor$45M Series B+ · May 2025
AAignostics$34M Series B+ · Oct 2024
EeTheRNA Immunotherapies$39M Series B+ · Aug 2022

Boehringer Ingelheim Venture Fund portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/srtd-biotech (get a free API key).